Janux Therapeutics JANX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's deferred tax assets and other non-current assets?
- Janux Therapeutics (JANX) reported deferred tax assets and other non-current assets of $3.94M in Q1 2026.
- How has Janux Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Janux Therapeutics's deferred tax assets and other non-current assets increased by 41.3% year-over-year, from $2.79M to $3.94M.